Skip to content
Trial Eligibility
Menu

Deep Brain Stimulation for Psychosis

NCT06257056

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

There are three hypotheses proposed for this study: 1) Participants will report no unanticipated serious adverse events during the eight months of treatment. 2) Investigators will successfully model psychotic versus non-psychotic brain states using support vector machine (SVM) classifiers. 3) Participants specific brain stimulation parameters can induce a change in the brain state consistent with non-psychotic states as measured by classifier output. Hypotheses 1, 2, and 3 address safety and tolerability, efficacy, and the putative mechanism of successful treatment.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Treatment-Refractory Schizophrenia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 to 70 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Bradley Lega
Last updated on ClinicalTrials.gov
June 9, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • UT Southwestern Medical Center · Dallas, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.